KIMBERLY MURPHY: Open Payments
NPI 1306557004 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 11 payments from 6 companies in 2025. Trend: 2023 $478 · 2024 $50 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $95 |
| Janssen Biotech, Inc. | 3 | $68 |
| ABBVIE INC. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Organon LLC | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, HADLIMA.
Industry payments across MD — which companies pay providers there.
